|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Change in fair value of contingent consideration | |||||
| Change in fair value of Contract Consideration Convertible Notes Payable | |||||
| Amortization of contract assets | |||||
| Depreciation | |||||
| Amortization of asset-based loan origination costs | |||||
| Amortization of deferred financing costs | |||||
| Paid-in-kind interest expense | |||||
| Provision for credit losses, net of recoveries | |||||
| Provision for excess and obsolete inventory | |||||
| Gain on sale of property and equipment | |||||
| Gain on lease termination | |||||
| Non-cash lease expense | |||||
| Stock compensation expense | |||||
| Deferred income tax (benefit) expense | |||||
| Paycheck protection plan loan forgiveness | |||||
| Changes in current assets and liabilities: | |||||
| Accounts receivable | |||||
| Accounts receivable, related party | |||||
| Inventories | |||||
| Income tax receivable | |||||
| Other assets | |||||
| Contract assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Operating lease liabilities | |||||
| Income taxes payable | |||||
| Interest payable | |||||
| Interest payable, related party | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment for forfeited stock options | |||||
| Payments on long term debt | |||||
| Proceeds from asset-based loan | |||||
| Payments on asset-based loan | |||||
| Payments of asset-based loan origination costs | |||||
| Payment of note payable issuance costs | |||||
| Proceeds from issuance of convertible notes | |||||
| Payment of issuance costs of convertible notes | |||||
| Proceeds from issuance of warrants | |||||
| Payment of stock warrant issuance costs | |||||
| Payments to tax authorities for shares withheld from employees | |||||
| Proceeds from issuance of stock under Employee Stock Purchase Plan | |||||
| Proceeds from stock option exercises | |||||
| Payments for finance leases | |||||
| Net cash used in financing activities | |||||
| Effect of changes in exchange rates on cash and cash equivalents | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Restricted cash at the beginning of the period | |||||
| Cash and cash equivalents and restricted cash at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
| Restricted cash at the end of the period | |||||
| Cash and cash equivalents and restricted cash at the end of the period | |||||
Loading...